https://www.businesswire.com/news/home/20191202005107/en/ > ST. HELIER, Jersey--(BUSINESS WIRE)--Dec 2, 2019-- > Novocure (NASDAQ: NVCR) and the American Association for Cancer Research (AACR) announce today their 2 nd Annual AACR-Novocure Grants for Tumor Treating Fields Research program. The program represents a joint effort to promote and support innovative research on Tumor Treating Fields to help deepen the understanding of the mechanism of action and to accelerate the development of new treatment strategies. The program includes research grants and career development awards totaling more than $2 million over the next three years.